Clinical trials in Poznan – page 15

943 clinical trials in Poznan, Poland across 11 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PolandBadaniaKliniczne.pl

Poznan at a glance

943

clinical trials

Research sites11

Quick filters

943 trials in Poznan

Open in trial search

Gastrointestinal cancer metastatic

Recruiting

Study of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment

InvestigationalNo placebo

Study of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment

InvestigationalNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Sunitinib
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Adrenogenital syndrome

Recruiting

A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

Investigational

A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:ATUMELNANT
Sponsor:Crinetics Pharmaceuticals Inc.

Contact Research Centre

HER2 positive endometrial cancer

Recruiting

Study of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer

Registered drugNo placebo

Study of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Daiichi Sankyo Inc.

Contact Research Centre

Squamous cell carcinoma of lung+8

Recruiting

A study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer

Registered drugNo placebo

A study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:BNT327
Sponsor:BioNTech SE

Contact Research Centre

Short-bowel syndrome

Recruiting

Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

Investigational

Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Glepaglutide
Sponsor:Zealand Pharma A/S

Contact Research Centre

Non-small cell lung cancer stage IIIA+2

Recruiting

Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

Registered drugNo placebo

Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Major depression

Recruiting

A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

Investigational

A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

Investigational

Poland

Participants:18–64 years · 65+ years
Sponsor:Seaport Therapeutics Inc.

Contact Research Centre

Non-small cell lung cancer

Recruiting

A Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment

Registered drugNo placebo

A Study of Telisotuzumab Adizutecan Compared to Standard Treatment in Adults with Advanced Non-Small Cell Lung Cancer After Previous Treatment

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Amivantamab
Sponsor:AbbVie Deutschland GmbH & Co. KG

Contact Research Centre

Multiple sclerosis

Recruiting

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Registered drug

A study of RO7268489 added to ocrelizumab compared to placebo in adults with progressive multiple sclerosis

Registered drug

Poland

Participants:18–64 years
Substances:Ocrelizumab
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

Recruiting

Registered drug

A Study of SAB-142 to Slow the Progression of Type 1 Diabetes in Adults and Children Recently Diagnosed with the Disease

Registered drug

Poland

Participants:0–17 years · 18–64 years
Substances:Sodium Chloride
Sponsor:Sab Biotherapeutics Inc.

Contact Research Centre

Crohn's disease

Recruiting

Study of icotrokinra for adults with moderately to severely active Crohn's disease

Investigational

Study of icotrokinra for adults with moderately to severely active Crohn's disease

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:ICOTROKINRA
Sponsor:Janssen Cilag International

Contact Research Centre

Colitis ulcerative

Recruiting

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Investigational

Testing icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis

Investigational

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:ICOTROKINRA
Sponsor:Janssen Cilag International

Contact Research Centre

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Poznan

What the registry says about research in the country

01 Immunology & Infectious Diseases

Clinical trials focusing on meningococcal vaccines and respiratory syncytial virus prevention. Studies include testing new conjugate vaccines in infants and evaluating immune responses in older adults.

Meningococcal infection prevention
RSV vaccination studies
Vaccine immunogenicity assessment

Multiple age groups are being studied to ensure comprehensive protection against infectious diseases.

02 Dermatology & Rheumatology

Innovative research into psoriatic conditions and inflammatory skin disorders. Studies evaluating new treatments for plaque psoriasis and psoriatic arthritis.

Moderate to severe plaque psoriasis
Psoriatic arthritis treatments
Atopic dermatitis therapy

Focus on developing targeted therapies for chronic inflammatory skin conditions.

03 Oncology

Advanced research in bladder cancer and other oncological conditions. Studies combining immunotherapy with traditional treatments for enhanced efficacy.

Non-muscle invasive bladder cancer
Metastatic prostate cancer
Gastric cancer treatments

Investigating novel combination therapies and targeted treatments for various cancer types.

04 Chronic Diseases

Comprehensive studies addressing chronic kidney disease, obesity, and cardiovascular conditions. Research focuses on innovative treatment approaches and disease management.

Heart failure prevention
Obesity management
Chronic kidney disease treatment

Evaluating new therapeutic options for long-term disease management and prevention.

Back to Poland All countries